We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,306.00
Bid: 2,306.00
Ask: 2,308.00
Change: -33.00 (-1.41%)
Spread: 2.00 (0.09%)
Open: 2,325.00
High: 2,393.00
Low: 2,306.00
Yest. Close: 2,339.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LONDON MARKET OPEN: Shares Open Firm Even As Hikma And ARM Sink

10 Feb 16 08:34

LONDON BRIEFING: Hikma And ARM Shares Sold After Pre-Market Updates

10 Feb 16 08:22

Hikma Pharmaceuticals Agrees USD535 Million Price Cut For Roxane Deal

10 Feb 16 07:30

Hikma cuts cash consideration for Roxane by £370m

(ShareCast News) - Hikma Pharmaceutical's takeover of Roxane Laboratories took on a new shape on Wednesday, with the cash consideration being almost halved off the back of significantly lower revenue projections. The FTSE 100 company had published a prospectus on 22 January in relation to the acquis

10 Feb 16 07:15

LONDON MARKET OPEN: Hikma Up, Hargreaves Lansdown Down In Soft Open

3 Feb 16 08:34

FTSE 100 movers: BP leads market fallers on losses

(ShareCast News) - The FTSE 100 was back below 6,000 on Tuesday, dropping 151.22 points (2.5%) to 5,908.88 by mid-afternoon. BP took the biggest hit after $2.6bn of write-downs and restructuring charges sent it crashing into losses for the fourth quarter and full year. A $3.31bn loss was reported f

2 Feb 16 14:13

BUZZ-Hikma: top of the FTSE 100 on BAML upgrade

** Hikma rises 3 pct after BAML upgrades to "buy" from "neutral" ** Says it sees generous synergies from Roxane Laboratories acquisition; expects co to shut either its own or Roxane's US generics manufacturing plant ** Adds minimal colour on current pipeline but some large opportuniti

2 Feb 16 09:21

BROKER RATINGS SUMMARY: JPMorgan Cuts Merlin To Underweight

14 Jan 16 09:43

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

5 Jan 16 09:43

Hikma Pharmaceuticals To Sell Ohio-Based Ben Venue Sites To Xellia

25 Nov 15 08:52

LONDON MARKET CLOSE: Stocks End Flat As Investors Await FOMC Minutes

18 Nov 15 16:51

LONDON MARKET MIDDAY: Fed Minutes Awaited For December Rate Hike Clues

18 Nov 15 12:18

WINNERS & LOSERS SUMMARY: Antofagasta, Anglo Up On Goldman Upgrades

18 Nov 15 10:16

LONDON MARKET OPEN: Hikma Shines Amid Downbeat European Markets

18 Nov 15 08:32

LONDON BRIEFING: Hikma And Hunting Gain Amid Weak Early Market

18 Nov 15 08:12

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.